Literature DB >> 22282009

[Dysplasia and laryngeal carcinoma in situ].

U Schroeder1, M P E Gebhard, B Wollenberg.   

Abstract

Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.

Entities:  

Mesh：

Year:  2012        PMID： 22282009     DOI： 10.1007/s00106-011-2424-7

Source DB:  PubMed          Journal:  HNO        ISSN： 0017-6192            Impact factor:   1.284


  10 in total

1.  Clinical, morphological and immunohistochemical aspects in laryngeal premalignant lesions.

Authors:  F Anghelina; Elena Ioniţă; Carmen Florina Popescu; I Ioniţă; Carmen Mogoantă; S Ciolofan; L Mogoantă
Journal:  Rom J Morphol Embryol       Date:  2006       Impact factor: 1.033

2.  Management of laryngeal dysplasia in the United Kingdom: a web-based questionnaire survey of current practice.

Authors:  V Paleri; K Mackenzie; R G Wight; H Mehanna; P Pracy; P J Bradley
Journal:  Clin Otolaryngol       Date:  2009-08       Impact factor: 2.597

3.  Genetic progression model for head and neck cancer: implications for field cancerization.

Authors:  J Califano; P van der Riet; W Westra; H Nawroz; G Clayman; S Piantadosi; R Corio; D Lee; B Greenberg; W Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

Review 4.  Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Authors:  K Cooper; H Squires; C Carroll; D Papaioannou; A Booth; R F Logan; C Maguire; D Hind; P Tappenden
Journal:  Health Technol Assess       Date:  2010-06       Impact factor: 4.014

5.  COX-2 expression in dysplasia of the head and neck: correlation with elF4E.

Authors:  C A Nathan; I L Leskov; M Lin; F W Abreo; R Shi; G H Hartman; J Glass
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

6.  Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.

Authors:  V A Papadimitrakopoulou; G L Clayman; D M Shin; J N Myers; A M Gillenwater; H Goepfert; A K El-Naggar; J S Lewin; S M Lippman; W K Hong
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-10

7.  Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Authors:  Nabil F Saba; Misun Choi; Susan Muller; Hyung Ju C Shin; Mourad Tighiouart; Vassiliki A Papadimitrakopoulou; Adel K El-Naggar; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-08

8.  15-Year review of laryngeal and oral dysplasias and progression to invasive carcinoma.

Authors:  Patrick M Spielmann; T Palmer; L McClymont
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-06-20       Impact factor: 2.503

Review 9.  Current review on squamous intraepithelial lesions of the larynx.

Authors:  Nina Gale; Leslie Michaels; Bostjan Luzar; Mario Poljak; Nina Zidar; Janez Fischinger; Antonio Cardesa
Journal:  Histopathology       Date:  2008-08-25       Impact factor: 5.087

10.  Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions.

Authors:  P Chatrath; I S Scott; L S Morris; R J Davies; S M Rushbrook; K Bird; S L Vowler; J W Grant; I T Saeed; D Howard; R A Laskey; N Coleman
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640
  10 in total
  2 in total

Review 1.  [Narrow band imaging for evaluation of laryngeal mucosal lesions].

Authors:  N Davaris; S Voigt-Zimmermann; A Roessner; C Arens
Journal:  HNO       Date:  2017-06       Impact factor: 1.284

2.  [Endoscopy of the larynx by hyperspectral imaging].

Authors:  A O H Gerstner; W Laffers; G Schade; F Göke; R Martin; B Thies
Journal:  HNO       Date:  2012-12       Impact factor: 1.284
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.